newsfilter
← Latest News
Business Wire·

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market

Spruce Biosciences, Inc. (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it